Revolve Biotechnologies Overview

  • Founded
  • 2013

  • Status
  • Private

  • Employees
  • 2

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Revolve Biotechnologies General Information


Developer of a protein and nucleic acid evolution technology designed to produce custom DNA libraries. The company's platform develops an ultra-affinity antibody discovery engine and has a pipeline of protein products in development, enabling healthcare researchers to create high-affinity antibodies for diagnostic and therapeutic applications, oncolytic cancer therapeutics, and infrared fluorescent proteins for live deep-tissue imaging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Primary Office
  • Schapiro 203
  • 2401 West Belvedere Avenue
  • Baltimore, MD 21215
  • United States
+1 (410) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Revolve Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 29-Sep-2020 Completed Startup
4. Grant 24-Aug-2015 00000 Completed Startup
3. Grant 07-Jan-2015 00000 Completed Startup
2. Grant 01-Jul-2013 $100K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Revolve Biotechnologies’s complete valuation and funding history, request access »

Revolve Biotechnologies Executive Team (4)

Name Title Board Seat Contact Info
Elad Firnberg Ph.D Founder & Board Member
You’re viewing 1 of 4 executive team members. Get the full list »

Revolve Biotechnologies Board Members (1)

Name Representing Role Since
Elad Firnberg Ph.D Revolve Biotechnologies Founder & Board Member 000 0000
To view Revolve Biotechnologies’s complete board members history, request access »

Revolve Biotechnologies Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revolve Biotechnologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Civilization Ventures Venture Capital Minority 000 0000 000000 0
The Innovation Space Accelerator/Incubator Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Revolve Biotechnologies’s complete investors history, request access »